Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | $0.93 | $222.17 M | -4.82 | 167 | $194.62 M | ||
Aldeyra Therapeutics, Inc. | $3.18 | $229.34 M | -7.57 | 10 | $0 | ||
Cidara Therapeutics, Inc. | $11.99 | $58.57 M | -1.59 | 69 | $63.91 M | ||
Checkpoint Therapeutics, Inc. | $2.11 | $68.32 M | -0.72 | 23 | $103,000 | ||
Corvus Pharmaceuticals, Inc. | $1.81 | $126.98 M | -3.98 | 28 | $0 | ||
eFFECTOR Therapeutics, Inc. | $0.18 | $6.16 M | -0.1 | 14 | $0 | ||
Elevation Oncology, Inc. | $2.85 | $192.87 M | -4.15 | 29 | $0 | ||
Gamida Cell Ltd. | $0.03 | $4.34 M | -0.04 | 143 | $1.78 M | ||
ImmunoGen, Inc. | $31.24 | $8.73 B | -111.55 | 277 | $108.78 M | ||
Iovance Biotherapeutics, Inc. | $7.27 | $2.18 B | -4.3 | 557 | $1.19 M | ||
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 | ||
Lexicon Pharmaceuticals, Inc. | $1.67 | $632.61 M | -2.11 | 285 | $1.20 M | ||
Seres Therapeutics, Inc. | $0.81 | $92.99 M | -1.04 | 233 | $126.33 M | ||
PDS Biotechnology Corporation | $3.13 | $106.92 M | -2.13 | 25 | $0 | ||
X4 Pharmaceuticals, Inc. | $0.55 | $169.62 M | -1.51 | 116 | $0 |